163 related articles for article (PubMed ID: 22054468)
1. [Clinical, pathologic and molecular characteristics of pulmonary high-grade neuroendocrine tumors].
Danel C
Ann Pathol; 2011 Nov; 31(5 Suppl):S76-8. PubMed ID: 22054468
[No Abstract] [Full Text] [Related]
2. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
4. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in lung carcinoid tumours. Is there a difference between atypical and typical carcinoids with and without metastasis?
Sands TJ; Soomro IN; Chaudry ZR; Ronan J
Histopathology; 2006 Dec; 49(6):653-4. PubMed ID: 17163851
[No Abstract] [Full Text] [Related]
6. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
Yeh YC; Chou TY
J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
Linnoila RI
J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis.
Arbiser ZK; Arbiser JL; Cohen C; Gal AA
Mod Pathol; 2001 Dec; 14(12):1195-9. PubMed ID: 11743040
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
11. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
Chetty R
Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
[TBL] [Abstract][Full Text] [Related]
13. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
Travis WD
Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
[TBL] [Abstract][Full Text] [Related]
15. Transthoracic needle biopsy in the diagnosis of large-cell neuroendocrine carcinoma of the lung.
Marmor S; Koren R; Halpern M; Herbert M; Rath-Wolfson L
Diagn Cytopathol; 2005 Oct; 33(4):238-43. PubMed ID: 16138368
[TBL] [Abstract][Full Text] [Related]
16. L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
Kim HS; Yi SY; Jun HJ; Ahn JS; Ahn MJ; Lee J; Kim Y; Cui ZY; Hong HJ; Kim JM; Li S; Hwang IG; Park K
APMIS; 2009 Feb; 117(2):140-6. PubMed ID: 19239436
[TBL] [Abstract][Full Text] [Related]
17. Divergent differentiation in neuroendocrine lung tumors.
Brambilla E; Lantuejoul S; Sturm N
Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
19. [Combined neoplasia of the lung: description of a case of adenocarcinoma mixed with typical carcinoid].
Cavazza A; Toffanetti R; Ferrari G; Piana S; Putrino I; Gardini G
Pathologica; 2001 Jun; 93(3):216-20. PubMed ID: 11433616
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
